CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...